ClinicalTrials.gov
public full text
Public Domain
LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer Patients
The aim of this trial is to find out if there are any differences in the profiles of acute and late adverse effects among men with low and intermediate risk prostate cancer treated either with low dose-rate brachytherapy or hypofractionated external radiotherapy (CyberKnife). Also the prostate specific antigen (PSA) responses and cost utility of each treatment will be analysed.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy#881998
- Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.#857017
- SBRT for Localized Prostate Cancer: CyberKnife vs. VMAT-FFF, a Dosimetric Study#247036
- Effectiveness of Localized Prostate Cancer Treatments#882158
- A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.#1094907
Record · ID 879811
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive